138
Innate Pharma SA
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions EUR
FY21:
FY22:
140
FY23:
148
FY24:
85.7
FY25:
46.7
(positive)
Change from FY21 to FY25
millions EUR
FY21:
129
FY22:
59.5
FY23:
27.2
FY24:
25.3
FY25:
16.0
Total assets
Change from FY21 to FY25
millions EUR
FY21:
267
FY22:
199
FY23:
175
FY24:
111
FY25:
62.7
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions EUR
FY21:
79.9
FY22:
41.3
FY23:
39.6
FY24:
33.0
FY25:
36.6
(negative)
Change from FY24 to FY25
millions EUR
FY21:
–
FY22:
–
FY23:
–
FY24:
69.2
FY25:
47.8
(positive)
Change from FY21 to FY25
millions EUR
FY21:
107
FY22:
54.2
FY23:
51.9
FY24:
8.83
FY25:
−21.7
Total liabilities & equity
Change from FY24 to FY25
millions EUR
FY21:
–
FY22:
–
FY23:
–
FY24:
111
FY25:
62.7
All amounts in millions EUR